Adult pneumococcal vaccine recommendations have been considered some of the most complicated vaccine recommendations to appropriately implement. The good news: Implementation just got simpler.
With two newly licensed pneumococcal conjugate vaccines (PCVs) on the market, the Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) aimed to make timely recommendations that are based on the best available evidence. This afforded an opportunity to simplify existing pneumococcal vaccine recommendations in order to improve vaccination coverage and reduce disparities in pneumococcal disease burden among adults
COMMENTARY
5 Things to Know About Pneumococcal Disease and the New Adult Pneumococcal Vaccine Recommendations
Miwako Kobayashi, MD, MPH
DisclosuresFebruary 17, 2022
Editorial Collaboration
Medscape &
Adult pneumococcal vaccine recommendations have been considered some of the most complicated vaccine recommendations to appropriately implement. The good news: Implementation just got simpler.
With two newly licensed pneumococcal conjugate vaccines (PCVs) on the market, the Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) aimed to make timely recommendations that are based on the best available evidence. This afforded an opportunity to simplify existing pneumococcal vaccine recommendations in order to improve vaccination coverage and reduce disparities in pneumococcal disease burden among adults
Join the Top Medical Resource for Physicians Today. Free Membership!
Credit:
Lead Image: iStock/Getty Images
Cite this: 5 Things to Know About Pneumococcal Disease and the New Adult Pneumococcal Vaccine Recommendations - Medscape - Feb 17, 2022.
Tables
References
Authors and Disclosures
Authors and Disclosures
Author
Miwako Kobayashi, MD
Medical Epidemiologist, Centers for Disease Control and Prevention, Atlanta, Georgia
Disclosure: Miwako Kobayashi, MD, MPH, has disclosed no relevant financial relationships.